Last updated on: 12/22/2011 | Author:

Rosalie Liccardo Pacula, PhD Biography

Acting Director of the Economics, Finance and Organization Unit at RAND Health
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“Different types of medical marijuana initiatives face different practical and legal problems. Research trials obviate the need for complex legislation and enforcement but at the cost of only providing legal access to cannabis for very small numbers of patients, at substantial cost… Patients who do not wish to participate in such trials do not have legal access to cannabis.

Laws that allow physicians to prescribe cannabis… face a number of problems. In the USA state prescription laws conflict with federal laws, exposing physicians and patients to the risk of federal criminal prosecution. Even in the absence of prosecution, physicians have been reluctant to prescribe cannabis because of uncertainty about the indications for its use. The organised medical profession also fears incurring legal liability for any harms that may be caused by chronic cannabis smoking.”

Cannabis Use and Dependence: Public Health and Public Policy, 2003

Involvement and Affiliations:
  • Acting Director, Economics, Finance and Organization Unit, RAND Health, 2009-present
  • Core Faculty, Pardee RAND Graduate School of Public Policy, 2007-present
  • Co-director, Drug Policy Research Center, RAND, 2005-present
  • Senior Economist, RAND, 2005-present
  • Faculty Research Fellow, National Bureau of Economic Research, 1997-present
  • Economist, RAND, 2002-2004
  • Associate Economist, RAND, 1998-2001
  • Visiting Senior Research Analyst, Health Research and Policy Centers, University of Illinois at Chicago, 1997-1998
  • Assistant Professor of Economics, School of Business Administration, University of San Diego, 1995-1998
  • PhD, Economics, Duke University, 1995
  • MA, Economics, Duke University, 1992
  • BS, Political Science and Economics, Santa Clara University, 1990
  • None found